CVS Health Corporation (CVS) Board Approves Quarterly Dividend As Cantor Fitzgerald and Bernstein Assert Bullishness

Source: Pexels

The dividend offering coincides with Cantor Fitzgerald reiterating CVS Health arsenic its preferred banal for Medicare Advantage vulnerability this year. According to the probe firm, the institution remains well-positioned to payment from a favorable regulatory environment.

Likewise, Bernstein raised its terms people for the banal to $87 from $86 portion reiterating a Market Perform rating. The terms people hike is successful effect to the probe firm’s touting of the palmy execution of a turnaround strategy. The probe steadfast besides views Aetna arsenic an charismatic maturation motor expected to thrust aboriginal show contempt headwinds successful the pharmacy payment environment. Bernstein expects CVS to payment from maturation successful pharmacy payment managers alongside an summation successful cause spend.

CVS Health Corporation (NYSE:CVS) is simply a large U.S. healthcare institution that integrates retail pharmacies (CVS Pharmacy), wellness security (Aetna), and pharmacy benefits absorption (CVS Caremark) to supply a connected wellness experience, offering everything from prescriptions and wellness products to security plans.

While we admit the imaginable of CVS arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 10 Best Penny Stocks to Buy for 2026 and 10 Best Metal Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.